Clinical Trial Update: Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating a combination of chemotherapy, bevacizumab, radiation therapy, and erlotinib in patients with stage III non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-19